<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02433379</url>
  </required_header>
  <id_info>
    <org_study_id>91026550</org_study_id>
    <nct_id>NCT02433379</nct_id>
  </id_info>
  <brief_title>Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction</brief_title>
  <acronym>UNTOUCHED</acronym>
  <official_title>Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study assesses the 18-month incidence of inappropriate shocks in subjects implanted with&#xD;
      the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) for primary prevention of sudden&#xD;
      cardiac death. Devices are to be programmed with zone cutoffs at 200 bpm and 250 bmp in order&#xD;
      to mimic the programming settings for transvenous ICDs in the MADIT RIT study. The incidence&#xD;
      of inappropriate S-ICD shocks will be compared to the incidence of inappropriate shocks&#xD;
      observed in the MADIT RIT study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Implantable cardioverter defibrillator (ICD) therapy is highly effective for reducing&#xD;
      mortality in patients with clinical markers for elevated risk for ventricular arrhythmias.&#xD;
      However, inappropriate shocks and unnecessary appropriate shocks remain an important side&#xD;
      effect that can significantly affect an ICD recipient's quality of life and may be&#xD;
      deleterious to the myocardium.&#xD;
&#xD;
      The MADIT RIT study demonstrated that the incidence of inappropriate and unnecessary&#xD;
      appropriate ICD therapy can be reduced in primary prevention patients through two different&#xD;
      programming strategies: 1) High Rate Zone Cutoff, i.e., raising the lowest rate detection&#xD;
      cutoff to 200 bpm; and 2) Delayed Therapy Initiation, i.e., increasing the time to therapy&#xD;
      initiation to 60 seconds for arrhythmias detected between 170-199 bpm and 12.5 seconds&#xD;
      between 200-249 bpm. Both strategies effectively reduced the amount of ICD therapy delivered&#xD;
      when compared to conventional programming, where the lowest rate detection cutoff was 170 bpm&#xD;
      and the delay to therapy initiation was programmed to 2.5 seconds. Importantly, neither&#xD;
      treatment arm was associated with significantly increased syncope or mortality. The results&#xD;
      of MADIT RIT established preferred device settings for reducing shocks in transvenous ICD&#xD;
      (TV-ICD) patients with a primary prevention indication.&#xD;
&#xD;
      Preferred settings for subcutaneous ICDs, however, have not been established with data from&#xD;
      prospective studies. The UNTOUCHED study will test a programming scheme designed to minimize&#xD;
      inappropriate and unnecessary shocks in patients who have an indication for primary&#xD;
      prevention of sudden cardiac death and low ejection fraction. Although S-ICD programming&#xD;
      options do not permit exact replication of the programmed settings previously shown to reduce&#xD;
      shocks in the MADIT RIT treatment arms, key elements are combined into the UNTOUCHED settings&#xD;
      to be tested in this protocol. It is hypothesized that despite the lack of anti-tachycardia&#xD;
      pacing, the EMBLEM S-ICD settings utilized in this study will result in an overall shock&#xD;
      incidence similar to that observed in ICD patients from MADIT RIT.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 9, 2015</start_date>
  <completion_date type="Actual">December 6, 2019</completion_date>
  <primary_completion_date type="Actual">December 6, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Patients Who Did Not Experience an Inappropriate Shock From Their EMBLEM S-ICD</measure>
    <time_frame>18 months</time_frame>
    <description>Primary endpoint: Inappropriate shock free rate from 0 to 540 Days (18-Months) compared to a performance goal of 91.6%.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Not Experiencing a System or Procedure Related Complication From 0 to 30 Days</measure>
    <time_frame>30 days</time_frame>
    <description>Secondary safety endpoint: Freedom from System and Procedure Related Complications at 30 days compared to a performance goal of 93.8%.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Subjects Free From All-cause Shock From Their EMBLEM S-ICD</measure>
    <time_frame>18 months</time_frame>
    <description>Secondary efficacy endpoint: All-Cause Shock Free Rate at 540 days (18-months) compared to a performance goal of 85.8%.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Percentage of Patients Not Experiencing a System or Procedure Related Complication From 0 to 180 Days (6 Months).</measure>
    <time_frame>6 months</time_frame>
    <description>Post-Market Clinical Follow-up (PMCF) Endpoint: Freedom from System and Procedure Related Complications at 180 days (6 months) compared to a performance goal of 85%. This analysis was conducted for two sub-groups of UNTOUCHED Study subjects: 1.) the first 200 subjects implanted with an EMBLEM model A209 device; 2.) the first 200 subjects implanted with an EMBLEM model A219 device. The PMCF analysis prespecified in the study protocol only required a sub-set of the implanted UNTOUCHED Study subjects (i.e., 200 subjects for the EMBLEM A209 analysis and 200 for the EMBLEM A219 analysis; the full study cohort was not required for these two analyses).</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1173</enrollment>
  <condition>Ventricular Fibrillation</condition>
  <condition>Ventricular Tachycardia</condition>
  <condition>Low Cardiac Output</condition>
  <arm_group>
    <arm_group_label>Single Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects implanted with an EMBLEM S-ICD with rate zones set at 200 bpm and 250 bpm per protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EMBLEM S-ICD System</intervention_name>
    <description>The intervention comprises programming the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) with zone cutoffs at 200 bpm and 250 bmp</description>
    <arm_group_label>Single Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with ischemic or non-ischemic heart disease who meets current guidelines for&#xD;
             ICD therapy and intends to undergo a de novo implant procedure for an EMBLEM™ S-ICD&#xD;
             (or newer generation BSC S-ICD)&#xD;
&#xD;
          -  Left ventricular ejection fraction ≤ 35%&#xD;
&#xD;
          -  A passing EMBLEM™ S-ICD (or newer generation BSC S-ICD) screening ECG&#xD;
&#xD;
          -  Patient ≥ 21 years of age willing and capable of giving informed consent&#xD;
&#xD;
          -  Patient willing and capable of complying with follow-up visits&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with a history of spontaneous sustained VT or VF&#xD;
&#xD;
          -  Patient with bradycardia pacing indication&#xD;
&#xD;
          -  Patient eligible and scheduled for cardiac resynchronization implant&#xD;
&#xD;
          -  Patient with a previous S-ICD or a previous transvenous pulse generator (pacemaker or&#xD;
             defibrillator)&#xD;
&#xD;
          -  Patient in NYHA Class IV documented in the medical records within 90 days before&#xD;
             enrollment&#xD;
&#xD;
          -  Patient with life expectancy shorter than 18 months due to any medical condition&#xD;
             (e.g., cancer, uremia, liver failure, etc…)&#xD;
&#xD;
          -  Patient receiving hemodialysis within 180 days before to enrollment&#xD;
&#xD;
          -  Patients unable to give consent in person, including patients unable to read or write&#xD;
&#xD;
          -  Patient who is known to be pregnant or plans to become pregnant over the course of the&#xD;
             trial&#xD;
&#xD;
          -  Patient unwilling or unable to cooperate with the protocol&#xD;
&#xD;
          -  Participation in concurrent clinical study without prior approval from Boston&#xD;
             Scientific&#xD;
&#xD;
          -  Medical status (e.g., hemodynamic conditions ) of the patient doesn't allow&#xD;
             programming devices with a conditional shock zone at 200 bpm and a shock zone at 250&#xD;
             bpm, in the judgment of the implanting physician and/or according to (inter) national&#xD;
             guidelines&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Gold, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lucas Boersma, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Antonius Ziekenhuis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alabama Cardiovascular Group</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huntsville Hospital - The Heart Center, PC</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Gilbert Medical Center</name>
      <address>
        <city>Gilbert</city>
        <state>Arizona</state>
        <zip>85297</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Phoenix</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glendale Adventist Medical Center</name>
      <address>
        <city>Glendale</city>
        <state>California</state>
        <zip>91206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sharp Grossmont Hospital</name>
      <address>
        <city>La Mesa</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Southern California Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033-4612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alta Bates Medical Center</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph Hospital</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital - San Jose</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harbor UCLA Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Physicians PA</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Medical Center</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tallahassee Memorial Hospital</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CorVita Science Foundation</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern Indiana Research Alliance - Lutheran Hospital</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Hospital of Indianapolis</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartland Cardiology</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Cardiovascular Specialists</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peninsula Cardiology Associates</name>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <zip>21804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph Mercy Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CardioVascular Institute of Michigan P.C.</name>
      <address>
        <city>Roseville</city>
        <state>Michigan</state>
        <zip>48066</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centracare Heart and Vascular Center</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HealthEast St. Joseph's Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Mississippi Medical Center</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Research</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cox Health</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HealthCare Partners Cardiology</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89169</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deborah Heart and Lung Center</name>
      <address>
        <city>Browns Mills</city>
        <state>New Jersey</state>
        <zip>08015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cooper Hospital - University Medical Center</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of the Delaware Valley</name>
      <address>
        <city>Sewell</city>
        <state>New Jersey</state>
        <zip>08080</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Strong Memorial Hospital of the University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Mission Hospital</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina Hospital</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Durham VA Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rex Hospital</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aultman Hospital</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Toledo Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesis Healthcare System</name>
      <address>
        <city>Zanesville</city>
        <state>Ohio</state>
        <zip>43701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Salem Hospital</name>
      <address>
        <city>Salem</city>
        <state>Oregon</state>
        <zip>97301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sacred Heart Medical Center at Riverbend</name>
      <address>
        <city>Springfield</city>
        <state>Oregon</state>
        <zip>97477</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abington Memorial Hospital</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <zip>19001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AnMed Health</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425-0001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Texas Veterans Health Care System</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trinity Mother Frances Health System</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah Hospital and Clinics</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centra Stroobants Cardiovascular Center</name>
      <address>
        <city>Lynchburg</city>
        <state>Virginia</state>
        <zip>24501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University Health System</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evergreen Hospital Medical Center</name>
      <address>
        <city>Kirkland</city>
        <state>Washington</state>
        <zip>98034</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHI Franciscan Health System</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53715</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Jean</name>
      <address>
        <city>Brussels</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Gent</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut universitaire de Cardiologie et de Pneumologie de Quebec</name>
      <address>
        <city>Ste-Foy</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Annecy</name>
      <address>
        <city>Annecy</city>
        <zip>74011</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU La Timone Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de la Pitie-Salpetriere</name>
      <address>
        <city>Paris</city>
        <zip>75151</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Hopital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nouvel Hôpital Civil De Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Nancy Brabois</name>
      <address>
        <city>Vandoeuvre Les Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unfallkrankenhaus Berlin Marzahn</name>
      <address>
        <city>Berlin</city>
        <zip>12687</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsmedizin Greifswald</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinik Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Muenster</name>
      <address>
        <city>Muenster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Papa Giovanni XXIII</name>
      <address>
        <city>Bergamo</city>
        <zip>24127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Pisana</name>
      <address>
        <city>Pisa</city>
        <zip>56127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Integrata di Verona</name>
      <address>
        <city>Verona</city>
        <zip>37126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3430 EM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus MC - University Medical Center Rotterdam</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 GD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centralny Szpital Kliniczny Uniwerytetu Medycznego</name>
      <address>
        <city>Lodz</city>
        <zip>92-213</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital San Lucas</name>
      <address>
        <city>Ponce</city>
        <zip>00733</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen De La Salud</name>
      <address>
        <city>Toledo</city>
        <zip>45004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiocentro Ticino</name>
      <address>
        <city>Lugano</city>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zuerich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Blackpool Victoria NHS Trust Direct</name>
      <address>
        <city>Blackpool</city>
        <zip>FY3 8NR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Russels Hall Hospital</name>
      <address>
        <city>Dudley</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glenfield Hospital</name>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiothoracic Centre</name>
      <address>
        <city>Liverpool</city>
        <zip>L14 3PE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Bartholomews Hospital</name>
      <address>
        <city>London</city>
        <zip>EC1A 7BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern General Hospital</name>
      <address>
        <city>Sheffield</city>
        <zip>S5 7AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southampton University Hospital</name>
      <address>
        <city>Southampton</city>
        <zip>S016 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Puerto Rico</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Austria</country>
    <country>New Zealand</country>
  </removed_countries>
  <reference>
    <citation>Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W; MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012 Dec 13;367(24):2275-83. doi: 10.1056/NEJMoa1211107. Epub 2012 Nov 6.</citation>
    <PMID>23131066</PMID>
  </reference>
  <reference>
    <citation>Gold MR, Knops R, Burke MC, Lambiase PD, Russo AM, Bongiorni MG, Deharo JC, Aasbo J, El Chami MF, Husby M, Carter N, Boersma L. The Design of the Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED). Pacing Clin Electrophysiol. 2017 Jan;40(1):1-8. doi: 10.1111/pace.12994. Epub 2017 Jan 15.</citation>
    <PMID>27943348</PMID>
  </reference>
  <results_reference>
    <citation>Boersma LV, El-Chami MF, Bongiorni MG, Burke MC, Knops RE, Aasbo JD, Lambiase PD, Deharo JC, Russo AM, Dinerman J, Shaik N, Barr CS, Carter N, Appl U, Brisben AJ, Stein KM, Gold MR. Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results. Heart Rhythm. 2019 Nov;16(11):1636-1644. doi: 10.1016/j.hrthm.2019.04.048. Epub 2019 May 10.</citation>
    <PMID>31082539</PMID>
  </results_reference>
  <results_reference>
    <citation>Gold MR, Lambiase PD, El-Chami MF, Knops RE, Aasbo JD, Bongiorni MG, Russo AM, Deharo JC, Burke MC, Dinerman J, Barr CS, Shaik N, Carter N, Stoltz T, Stein KM, Brisben AJ, Boersma LVA; UNTOUCHED Investigators*. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial. Circulation. 2021 Jan 5;143(1):7-17. doi: 10.1161/CIRCULATIONAHA.120.048728. Epub 2020 Oct 19.</citation>
    <PMID>33073614</PMID>
  </results_reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>April 23, 2015</study_first_submitted>
  <study_first_submitted_qc>April 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2015</study_first_posted>
  <results_first_submitted>November 16, 2020</results_first_submitted>
  <results_first_submitted_qc>December 15, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 8, 2021</results_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
    <mesh_term>Cardiac Output, Low</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 10, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/79/NCT02433379/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>UNTOUCHED Study Participants</title>
          <description>There were 1173 patients who were consented for participation in the UNTOUCHED Study. Of the 1173 participants enrolled 1116 were implanted or attempted for implant with an EMBLEM S-ICD and programmed with rate zones set at 200 bpm and 250 bpm per protocol. There were 57 enrolled subjects who were determined to be screen failures or were not attempted for implant. These subjects were not followed for the study and therefore not included in the study analyses/results.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1173"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="852"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="321"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Screen Failures</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Total Withdrawals</title>
              <participants_list>
                <participants group_id="P1" count="209"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>UNTOUCHED Study subjects who were implanted or attempted for implant are included in the Baseline Demographics.</population>
      <group_list>
        <group group_id="B1">
          <title>UNTOUCHED Implanted/Attempted Subjects</title>
          <description>UNTOUCHED Study subjects who were implanted or attempted for implant with an EMBLEM S-ICD with rate zones set at 200 bpm and 250 bpm per protocol.&#xD;
EMBLEM S-ICD System: The intervention comprises programming the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) with zone cutoffs at 200 bpm and 250 bmp.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1116"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.8" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="286"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="830"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="704"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="239"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Puerto Rico</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="807"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Europe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="292"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Patients Who Did Not Experience an Inappropriate Shock From Their EMBLEM S-ICD</title>
        <description>Primary endpoint: Inappropriate shock free rate from 0 to 540 Days (18-Months) compared to a performance goal of 91.6%.</description>
        <time_frame>18 months</time_frame>
        <population>All implanted subjects were included in the analysis except for one participant who was co-enrolled in another study that may have affected the results of this analysis. There were 4 subjects who were attempted to be implanted but did not receive a device and therefore not included in the analysis. The endpoint was analyzes using intent to treat analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>S-ICD</title>
            <description>Subjects implanted with an EMBLEM S-ICD with rate zones set at 200 bpm and 250 bpm per protocol.&#xD;
EMBLEM S-ICD System: The intervention comprises programming the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) with zone cutoffs at 200 bpm and 250 bmp</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients Who Did Not Experience an Inappropriate Shock From Their EMBLEM S-ICD</title>
          <description>Primary endpoint: Inappropriate shock free rate from 0 to 540 Days (18-Months) compared to a performance goal of 91.6%.</description>
          <population>All implanted subjects were included in the analysis except for one participant who was co-enrolled in another study that may have affected the results of this analysis. There were 4 subjects who were attempted to be implanted but did not receive a device and therefore not included in the analysis. The endpoint was analyzes using intent to treat analysis.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1111"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.9" lower_limit="94.8" upper_limit="NA">As prespecified in the study protocol the lower one-sided 95% confidence bound of the Kaplan-Meier estimate was compared to the performance goal (i.e., only the lower one-side confidence bound was necessary/utilized for hypothesis testing).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Not Experiencing a System or Procedure Related Complication From 0 to 30 Days</title>
        <description>Secondary safety endpoint: Freedom from System and Procedure Related Complications at 30 days compared to a performance goal of 93.8%.</description>
        <time_frame>30 days</time_frame>
        <population>All implanted and attempted subjects were included in the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>S-ICD</title>
            <description>Subjects implanted with an EMBLEM S-ICD with rate zones set at 200 bpm and 250 bpm per protocol.&#xD;
EMBLEM S-ICD System: The intervention comprises programming the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) with zone cutoffs at 200 bpm and 250 bmp</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Not Experiencing a System or Procedure Related Complication From 0 to 30 Days</title>
          <description>Secondary safety endpoint: Freedom from System and Procedure Related Complications at 30 days compared to a performance goal of 93.8%.</description>
          <population>All implanted and attempted subjects were included in the analysis.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.8" lower_limit="94.7" upper_limit="NA">As prespecified in the study protocol the lower one-sided 95% confidence bound of the Kaplan-Meier estimate was compared to the performance goal (i.e., only the lower one-side confidence bound was necessary/utilized for hypothesis testing).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Subjects Free From All-cause Shock From Their EMBLEM S-ICD</title>
        <description>Secondary efficacy endpoint: All-Cause Shock Free Rate at 540 days (18-months) compared to a performance goal of 85.8%.</description>
        <time_frame>18 months</time_frame>
        <population>All implanted subjects were included in the analysis except for one participant who was co-enrolled in another study that may have affected the results of this analysis. There were 4 subjects who were attempted to be implanted but did not receive a device and therefore not included in the analysis. The endpoint was analyzes using intent to treat analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>S-ICD</title>
            <description>Subjects implanted with an EMBLEM S-ICD with rate zones set at 200 bpm and 250 bpm per protocol.&#xD;
EMBLEM S-ICD System: The intervention comprises programming the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) with zone cutoffs at 200 bpm and 250 bmp</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects Free From All-cause Shock From Their EMBLEM S-ICD</title>
          <description>Secondary efficacy endpoint: All-Cause Shock Free Rate at 540 days (18-months) compared to a performance goal of 85.8%.</description>
          <population>All implanted subjects were included in the analysis except for one participant who was co-enrolled in another study that may have affected the results of this analysis. There were 4 subjects who were attempted to be implanted but did not receive a device and therefore not included in the analysis. The endpoint was analyzes using intent to treat analysis.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1111"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.6" lower_limit="89.0" upper_limit="NA">As prespecified in the study protocol the lower one-sided 95% confidence bound of the Kaplan-Meier estimate was compared to the performance goal (i.e., only the lower one-side confidence bound was necessary/utilized for hypothesis testing).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Percentage of Patients Not Experiencing a System or Procedure Related Complication From 0 to 180 Days (6 Months).</title>
        <description>Post-Market Clinical Follow-up (PMCF) Endpoint: Freedom from System and Procedure Related Complications at 180 days (6 months) compared to a performance goal of 85%. This analysis was conducted for two sub-groups of UNTOUCHED Study subjects: 1.) the first 200 subjects implanted with an EMBLEM model A209 device; 2.) the first 200 subjects implanted with an EMBLEM model A219 device. The PMCF analysis prespecified in the study protocol only required a sub-set of the implanted UNTOUCHED Study subjects (i.e., 200 subjects for the EMBLEM A209 analysis and 200 for the EMBLEM A219 analysis; the full study cohort was not required for these two analyses).</description>
        <time_frame>6 months</time_frame>
        <population>The first 200 UNTOUCHED Study subjects implanted with an EMBLEM model A209 device as well as the first 200 UNTOUCHED Study subjects implanted with an EMBLEM model A219 device</population>
        <group_list>
          <group group_id="O1">
            <title>S-ICD (EMBLEM Model A209)</title>
            <description>The first 200 subjects implanted with an EMBLEM S-ICD (Model A209) S-ICD with rate zones set at 200 bpm and 250 bpm per protocol.&#xD;
EMBLEM S-ICD System: The intervention comprises programming the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) with zone cutoffs at 200 bpm and 250 bmp</description>
          </group>
          <group group_id="O2">
            <title>S-ICD (EMBLEM Model A219)</title>
            <description>The first 200 subjects implanted with an EMBLEM S-ICD (Model A219) S-ICD with rate zones set at 200 bpm and 250 bpm per protocol.&#xD;
EMBLEM S-ICD System: The intervention comprises programming the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) with zone cutoffs at 200 bpm and 250 bmp</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Patients Not Experiencing a System or Procedure Related Complication From 0 to 180 Days (6 Months).</title>
          <description>Post-Market Clinical Follow-up (PMCF) Endpoint: Freedom from System and Procedure Related Complications at 180 days (6 months) compared to a performance goal of 85%. This analysis was conducted for two sub-groups of UNTOUCHED Study subjects: 1.) the first 200 subjects implanted with an EMBLEM model A209 device; 2.) the first 200 subjects implanted with an EMBLEM model A219 device. The PMCF analysis prespecified in the study protocol only required a sub-set of the implanted UNTOUCHED Study subjects (i.e., 200 subjects for the EMBLEM A209 analysis and 200 for the EMBLEM A219 analysis; the full study cohort was not required for these two analyses).</description>
          <population>The first 200 UNTOUCHED Study subjects implanted with an EMBLEM model A209 device as well as the first 200 UNTOUCHED Study subjects implanted with an EMBLEM model A219 device</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="200"/>
                <count group_id="O2" value="200"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.5" lower_limit="89.9" upper_limit="NA">As prespecified in the study protocol the lower one-sided 95% confidence bound of the Kaplan-Meier estimate was compared to the performance goal (i.e., only the lower one-side confidence bound was necessary/utilized for hypothesis testing).</measurement>
                    <measurement group_id="O2" value="93.5" lower_limit="89.9" upper_limit="NA">As prespecified in the study protocol the lower one-sided 95% confidence bound of the Kaplan-Meier estimate was compared to the performance goal (i.e., only the lower one-side confidence bound was necessary/utilized for hypothesis testing).</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected from the time of enrollment until subjects ended their participation in the study. Subjects were considered to have completed the study after 18-Months of follow-up.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>S-ICD</title>
          <description>Subjects implanted with an EMBLEM S-ICD with rate zones set at 200 bpm and 250 bpm per protocol.&#xD;
EMBLEM S-ICD System: The intervention comprises programming the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) with zone cutoffs at 200 bpm and 250 bmp</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="57" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="354" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal laboratory values</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Hematological</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Pulseless Electrical Activity (PEA)</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Ventricular Fibrillation (VF)</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Ventricular Tachycardia (VT)/Monomorphic VT</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation (AF)</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Atrial Flutter</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Atrial Tachycardia/Other SVT (eg AVRT, AVNRT, EAT)</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Premature Ventricular Contractions (PVC)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Syncope - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Dizziness - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Chest pain - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Dyspnea - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Peripheral edema - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Pulmonary edema - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Fatigue - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Hypotension - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Weight gain - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Heart failure symptoms - Unspecified</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Multiple heart failure symptoms</sub_title>
                <counts group_id="E1" subjects_affected="91" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Hypertension - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Multi-system failure - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Mitral regurgitation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Valvular damage/Valvular insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Intermittent ST elevation during implant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>LBBB</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Myocardial biopsy (dilated cardiomyopathy of unknown origin)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Volume overload</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Endocrine</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Chest pain - Other</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Fatigue/Weakness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Multiple symptoms</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Adverse reaction - Medication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Head, eyes, ears, nose, throat (HEENT)</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Cancer</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Multi-system failure</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Drug related</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Weight loss</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse reaction - Allergic reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Systemic infection</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Fever and/or Virus</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Localized Infection</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Incisional/Superficial infection (= 30d post implant without explant)</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Device system infection (= 30d post implant with explant)</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Suspected infection Incisional/Superficial (= 30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Incisional/Superficial infection (&gt;30d post implant without explant)</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Device system infection (&gt;30d post implant with explant)</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Localized infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Strep infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Hematoma - Unrelated (non study) procedure or device</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Hemorrhage - Unrelated (non study) procedure or device</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Physical trauma</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Suboptimal electrode position</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Unable to convert VT/VF with S-ICD</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Post-surgical wound discomfort PG site (= 30d post implant) Procedure</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Electrode migration/revision Procedure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Adverse reaction Respiratory Procedure</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Adverse reaction Hypotension Procedure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Adverse reaction Medication/Anaphylactic shock Procedure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Sub-optimal electrode position</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inadvertent arrhythmia Procedure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Hematoma PG pocket (= 30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Hemodynamic instability DFT testing Procedure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Device system discomfort (&gt; 30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Post-surgical wound discomfort PG site (&gt; 30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Patient fall</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Positioning during procedure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Postoperative urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Electrode migration/revision</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>PG migration Subject</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Fascial defect closure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Neurological</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Dislodgment - Oversensing - RV Lead</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Premature cell battery depletion - PG</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inappropriate tachy therapy NSC (Cardiac oversensing) Electrode</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Out of Range shock impedance Electrode</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inappropriate tachy therapy NSR (Cardiac oversensing) System</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inappropriate tachy therapy noise (Non-cardiac) System</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inappropriate therapy SVT above programmed rate zone System</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inappropriate therapy SVT discrimination error System</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Oversensing System</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Device shocked 5 times before conversion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Non VT/VF cardiac oversensing AF</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychological</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Genitourinary</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>COPD exacerbation</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Pulmonary</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Hypoxemic respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Integumentary</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>PG erosion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Electrode erosion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Electrode suture discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inadequate healing of incision site Subject</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension/Orthostatic Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Hypertension/Hypertensive Crisis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disease</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Chest pain - Ischemic</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Transient Ischemic Attack (TIA)</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Accident (CVA) - unspecifed</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Deep Vein Thrombosis (DVT)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism (PE)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Distal thromboemboli</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Accident (CVA) - ischemic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Accident (CVA) - hemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Vasovagal reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="155" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal laboratory values</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Ventricular Tachycardia (VT)/Monomorphic VT</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation (AF)</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Atrial Flutter</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Chest pain - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Dyspnea - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Pulmonary edema - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Dehydration - Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Multiple heart failure symptoms</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Syncope related to VT/VF Subject</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>VT/VF below programming rate</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Chest pain - Other</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Fatigue/Weakness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Adverse reaction - General</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Head, eyes, ears, nose, throat (HEENT)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Systemic infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Incisional/Superficial infection (= 30d post implant without explant)</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Suspected infection Incisional/Superficial (= 30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Incisional/Superficial infection (&gt;30d post implant without explant)</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Suspected infection Incision/Superficial (&gt;30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Physical trauma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Electrode suture discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Unable to convert VT/VF with S-ICD</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Post-surgical wound discomfort PG site (= 30d post implant) Procedure</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Physical trauma Procedure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Scar Cyst/Keloid Procedure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Electrode movement Procedure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Adverse reaction Respiratory Procedure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Adverse reaction Hypotension Procedure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Adverse reaction Medication/Anaphylactic shock Procedure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Adverse reaction HF symptoms Procedure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Incomplete header/electrode connection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inadvertent arrhythmia Procedure</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Hematoma PG pocket (= 30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Hematoma Electrode incision (= 30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Seroma PG pocket (= 30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Post-surgical bleeding/hemorrhage (= 30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Device system discomfort (&gt; 30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Acute blood loss</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>AF during conversion testing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Vomiting during anesthesia induction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>PG movement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Neurological</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Inappropriate tachy therapy noise (Non-Cardiac) PG</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inappropriate therapy Baseline shift PG</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inappropriate tachy therapy NSC (Cardiac oversensing) Electrode</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Electrode migration/revision</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Random component failure Therapy available System</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inappropriate tachy therapy NSR (Cardiac oversensing) System</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inappropriate tachy therapy noise (Non-cardiac) System</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inappropriate therapy SVT above programmed rate zone System</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inappropriate therapy SVT discrimination error System</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inappropriate therapy Baseline shift System</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Intermittent sensing/undersensing System</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Oversensing System</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Non VT/VF cardiac oversensing</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Non VT/VF cardiac oversensing AF</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Non VT/VF cardiac oversensing for AF</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>T-wave oversensing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>User error programmer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Genitourinary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>COPD exacerbation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Pulmonary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Integumentary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>PG erosion (= 30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Post-surgical wound discomfort PG site (&gt; 30d post implant)</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Inadequate healing of incision site Subject</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Suture revision</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Outcome of elective MV and LAA closure surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Chest pain - Ischemic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
              <event>
                <sub_title>Transient Ischemic Attack (TIA)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1116"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study endpoints are compared against a performance goal rather than to a randomized control arm.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Paji Vitoff, Manager, Clinical Trials</name_or_title>
      <organization>Boston Scientific</organization>
      <phone>651-582-5415</phone>
      <email>Paji.Vitoff@bsci.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

